Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sugiyama

Showing results (11-20 of 19,939) with videos related to

Pageof 1,994
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 14, 2019
Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use"Toshihiro Sugiyama
Environmental Health Insights|May 17, 2011
Environments for active lifestyles: sustainable environments may enhance human healthTakemi Sugiyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 29, 2011
[108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Correlation between pulmonary diseases and whole body; (5) pulmonary diseases and abdominal viscera]Yukihiko Sugiyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[Second-line treatment using novel chemotherapeutic and biologic agents]Toru Sugiyama
Kidney International|June 24, 2019
Chronic kidney disease and fracture risk: a mechanistic insightToshihiro Sugiyama
Annals of the Rheumatic Diseases|June 2, 2019
Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritisToshihiro Sugiyama
The Journal of Clinical Endocrinology and Metabolism|July 11, 2019
Letter to the Editor: "Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment"Toshihiro Sugiyama
Hepatology (Baltimore, Md.)|May 18, 2019
Letter to the Editor: Bone Health in Nonalcoholic Fatty Liver Disease: A Mechanistic InsightToshihiro Sugiyama
Gastroenterology|May 19, 2019
Understanding the Current Evidence on Proton Pump Inhibitor Use and Bone HealthToshihiro Sugiyama
Physical Review Letters|March 29, 1993
Localization in a random magnetic field in 2DSugiyama, Nagaosa
Pageof 1,994

Showing results (11-20 of 19,939) with videos related to

Sort By:
Pageof 1,994
The Journal of Clinical Endocrinology and Metabolism|August 14, 2019
Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use"Toshihiro Sugiyama
Environmental Health Insights|May 17, 2011
Environments for active lifestyles: sustainable environments may enhance human healthTakemi Sugiyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 29, 2011
[108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Correlation between pulmonary diseases and whole body; (5) pulmonary diseases and abdominal viscera]Yukihiko Sugiyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[Second-line treatment using novel chemotherapeutic and biologic agents]Toru Sugiyama
Kidney International|June 24, 2019
Chronic kidney disease and fracture risk: a mechanistic insightToshihiro Sugiyama
Annals of the Rheumatic Diseases|June 2, 2019
Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritisToshihiro Sugiyama
The Journal of Clinical Endocrinology and Metabolism|July 11, 2019
Letter to the Editor: "Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment"Toshihiro Sugiyama
Hepatology (Baltimore, Md.)|May 18, 2019
Letter to the Editor: Bone Health in Nonalcoholic Fatty Liver Disease: A Mechanistic InsightToshihiro Sugiyama
Gastroenterology|May 19, 2019
Understanding the Current Evidence on Proton Pump Inhibitor Use and Bone HealthToshihiro Sugiyama
Physical Review Letters|March 29, 1993
Localization in a random magnetic field in 2DSugiyama, Nagaosa
Pageof 1,994